Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Benchmark Downgrades Emergent BioSolutions to Hold

Benchmark Downgrades Emergent BioSolutions to Hold

Benchmark analyst Robert Wasserman downgrades Emergent BioSolutions (NYSE:EBS) from Buy to Hold.

November 10, 2022

1 minute read

Benchmark analyst Robert Wasserman downgrades Emergent BioSolutions (NYSE:EBS) from Buy to Hold.

Crypto Named After Musk’s Pet Soars 19%, Beating Bitcoin, Ethereum Gains As Holders Vote To Burn $55M Tokens

January 30, 12:49 AM

FLOKI (CRYPTO: FLOKI) is surging over 19% in the last 24 hours, beating Bitcoin (CRYPTO: BTC) and Ethereum (CRYPTO: ETH) gains.

August 13, 11:08 AM

“Rich Dad, Poor Dad” author Robert Kiyosaki on Saturday took to X to sing one of his favorite investment tunes.

August 31, 8:36 AM

TikTok parent ByteDance Ltd looks to slash the price of its stock options to talented employees and attract good hires following…

October 20, 4:45 PM

In the current market session, Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) stock price is at $361.86, after a 0.81% decrease.…